Ibáñez-Botella Guillermo, González-García Laura, Carrasco-Brenes Antonio, Ros-López Bienvenido, Arráez-Sánchez Miguel Ángel
Neurosurgery Department, Regional University Hospital, Carlos Haya Avenue, 29010, Málaga, Spain.
Neurosurg Rev. 2017 Oct;40(4):605-611. doi: 10.1007/s10143-017-0813-4. Epub 2017 Jan 30.
The diagnostic criteria and management of this condition continue to be a topic of debate in the literature. The term definitive symptomatic LOVA (longstanding overt ventriculomegaly in adults) is applied to patients that fulfil a series of diagnostic criteria,which are reviewed in our paper. The main subject of our study is to propose a rearrangement of the criteria for the diagnosis of this entity and adjusted treatment strategies. We present our data evaluating the role of endoscopy in this pathology. This descriptive and analytical study comprised 27 adult patients with LOVA who underwent endoscopic third ventriculostomy (ETV). Data regarding age, gender and onset of symptoms, a previously implanted shunt, clinical examination and radiological findings at the time of diagnosis, and the intracranial pressure (ICP) recordings in some cases, were carefully retrospectively reviewed. ETV success was determined based on clinical state and radiological criteria. ETV was performed in all 27 cases. Mean follow up period was 4.2 years (6 months to 8 years). 2/27 patients (7.40%) were lost to follow-up. The overall success rate for ETV was 76% (21/25 patients). ETV resulted in shunt independency in two of the three patients with a previous shunt. Based on our results, we believe that ETV must be considered as the treatment of choice for patients with symptomatic LOVA.
这种疾病的诊断标准和治疗方法在文献中仍然是一个有争议的话题。术语“明确症状性成人长期明显脑室扩大(LOVA)”适用于符合一系列诊断标准的患者,这些标准将在我们的论文中进行综述。我们研究的主要目的是提出对该实体诊断标准的重新排列和调整后的治疗策略。我们展示了评估内镜检查在这种病理状况中作用的数据。这项描述性和分析性研究包括27例接受内镜下第三脑室造瘘术(ETV)的成人LOVA患者。仔细回顾了有关年龄、性别和症状发作、先前植入的分流器、诊断时的临床检查和影像学发现以及部分病例的颅内压(ICP)记录等数据。ETV的成功与否根据临床状态和影像学标准来确定。所有27例患者均接受了ETV。平均随访期为4.2年(6个月至8年)。27例患者中有2例(7.40%)失访。ETV的总体成功率为76%(25例患者中的21例)。ETV使3例先前有分流器的患者中的2例不再需要分流器。基于我们的结果,我们认为ETV必须被视为有症状性LOVA患者的首选治疗方法。